Ingevity Corporation NGVT NYSE

Ingevity Corporation (NGVT) reported total assets of $1.65B and total liabilities of $1.62B for fiscal year 2025, resulting in total equity of $29.7M.

The company held $78.1M in cash and short-term investments. Total debt stood at $1.24B, with net debt of $1.16B. The Debt-to-Equity (D/E) ratio was 41.84 (leveraged).

Current ratio is 1.15, suggesting adequate short-term liquidity. Interest coverage is 3.6x (adequate).

Criteria supported by this page:

• HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (60/100) — Total assets $1.65B and equity $29.7M support the company's competitive scale
• VALUE (72/100) — Debt-to-Equity 41.84 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

ESI

Element Solutions Inc

$37.53

-1.73%

ELVR

Elevra Lithium Limited

$63.96

+1.03%

AAUC

Allied Gold Corporation

$31.86

+0.44%

SXT

Sensient Technologies Corporation

$92.01

-1.42%

SKE

Skeena Resources Limited

$32.05

-3.93%

CC

The Chemours Company

$23.03

+0.61%

FUL

H.B. Fuller Company

$61.39

-2.51%

OLN

Olin Corporation

$27.76

-1.46%